Physician

Sudhir Manda, MD

According to 2025 Medicare claims, Sudhir Manda, MD (NPI: 1164630679) practices hematology/oncology in the Tucson, AZ market, with the plurality of this provider's patient population coming from Pima, AZ. This provider's primary affiliated billing organization is TMC MEDICAL NETWORK (NPI: 1750832283; TIN: 811156192) and primary practice location at 85711-2701. Manda is affiliated with the Abacus Health LLC (ACO ID: A2811) and ABC Network (ACO ID: A5554), participating under the MSSP model.

Manda's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 536 traditional Medicare patients, billed 187,790 HCPCS/CPT codes, and received $1,847,098 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 794 prescription claims across 171 beneficiaries totaling $3,984,649 in drug costs, led by Revlimid (Lenalidomide). 2020 DME data shows 25 claims. Open Payments data shows 191 records totaling $3,007,051. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $42,684 to $3,984,649. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.6M2015 Medicare payment: $15,216 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $639,772 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,795,170 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,864,578 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,640,579 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,250,157 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,387,627 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,400,112 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,609,701 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,847,098 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201548107$15,216
201629441,761$639,772
2017572159,746$1,795,170
2018517164,251$1,864,578
2019549183,319$2,640,579
2020597214,336$2,250,157
2021702197,869$2,387,627
2022621197,239$2,400,112
2023555175,864$1,609,701
2024536187,790$1,847,098

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.9M$5.8M2015 Drug cost: $42,684 (USD; Tot_Drug_Cst)2016 Drug cost: $1,027,261 (USD; Tot_Drug_Cst)2017 Drug cost: $2,587,520 (USD; Tot_Drug_Cst)2018 Drug cost: $1,782,391 (USD; Tot_Drug_Cst)2019 Drug cost: $2,393,297 (USD; Tot_Drug_Cst)2020 Drug cost: $3,520,123 (USD; Tot_Drug_Cst)2021 Drug cost: $5,791,204 (USD; Tot_Drug_Cst)2022 Drug cost: $4,751,207 (USD; Tot_Drug_Cst)2023 Drug cost: $3,545,593 (USD; Tot_Drug_Cst)2024 Drug cost: $3,984,649 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151977$42,684
2016116755$1,027,261
20172081,333$2,587,520
2018196991$1,782,391
2019202999$2,393,297
20202551,147$3,520,123
20212211,146$5,791,204
2022171834$4,751,207
2023147745$3,545,593
2024171794$3,984,649

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$4.9K$9.8K2016 Medicare payment: $9,814 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $4,621 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $4,001 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $6,720 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $1,772 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R28$9,814
2017N/R13$4,621
2018N/R16$4,001
2019N/R54$6,720
2020N/R25$1,772
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more131371$130
96413Administration of chemotherapy into vein, 1 hour or less85184$96
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more90121$96
36591Collection of blood sample from implanted device95171$19
96372Injection of drug or substance under skin or into muscle97224$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide701,883$1,498,455
PomalystPomalidomide31868$738,290
LenalidomideLenalidomide551,519$709,939
CalquenceAcalabrutinib Maleate26780$386,889
BrukinsaZanubrutinib14420$196,677

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.94$1,743Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.97$3,005,309Amgen Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sudhir Manda, MD?

Tedicare shows public-source Medicare data for Sudhir Manda, MD (NPI 1164630679), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sudhir Manda, MD have ACO affiliation data?

Sudhir Manda, MD is shown with ACO affiliation data for Abacus Health LLC (MSSP, ACO ID A2811) and ABC Network (MSSP, ACO ID A5554).

What billing organization is linked to Sudhir Manda, MD?

Sudhir Manda, MD is linked to TMC MEDICAL NETWORK (billing NPI 1750832283) in the available physician profile data.

Does Sudhir Manda, MD have Open Payments data?

Sudhir Manda, MD has 191 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.